Pregnant with metastatic neuroendocrine tumour of the ovary: what now?

Por Pistilli, B, Grana, CM, Fazio, N, Cavaliere, A, Ferrari, ME, Bodei, L, Baio, SM, Scambia, G, Paganelli, G, Peccatori, FA
Publicado em 2012

“Short Course” of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (P...

Por Rossi, D., Pistilli, B., Morale, D., Baldelli, Casadei, V., Benedetti, G., Alessandroni, P., Catalano, V., Giordani, P., Graziano, F., Fedeli, S. Luzi, Fiorentini, G.
Publicado no World J Oncol (2011)

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

Por Pistilli, B., Pluard, T., Urruticoechea, A., Farci, D., Kong, A., Bachelot, T., Chan, S., Han, H. S., Jerusalem, G., Urban, P., Robinson, D., Mouhaër, S. L., Tomaso, E. D., Massacesi, C., Saura, C.
Publicado no Breast Cancer Res Treat (2017)

1710P International multicentric evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits (TV) during the COVID-19 outbreak

Por Bizot, A., Heudel, P-E., Karimi, M., Levy, C., Vanlemmens, L., Uzan, C., Deluche, E., Genet, D., Saghatchian, M., Giacchetti, S., Grenier, J., Patsouris, A., Dieras, V.C., Pierga, J-Y., Petit, T., Ladoire, S., Jacot, W., Delaloge, S., Lambertini, M., Pistilli, B.
Publicado no Ann Oncol (2020)